Related Experiment Video
Updated: Jan 2, 2026

Mucin Agarose Gel Electrophoresis: Western Blotting for High-molecular-weight Glycoproteins
Published on: June 14, 2016
[MOLECULAR GENETIC ASPECTS OF THE DEVELOPMENT OF THE MUCOPOLYSACCHARIDOSES (REVIEW)]
G Zharmakhanova1, L Syrlybayeva1, E Nurbaulina2
1West Kazakhstan Marat Ospanov Medical University, 1Department of molecular biology and medical genetics, Aktobe, Kazakhstan.
Abstract:
The review highlights the current knowledge about the potential role of glycosaminoglycans in the induction of inflammation and development of damage of the functional systems of the organs by mucopolysaccharides (MPS). Undegraded glycosaminoglycans are stimulants of secondary events in the form of complex pathogenetic cascades: accumulation of secondary substrates unrelated to the defective enzyme, abnormal composition of the membranes, disorders of intracellular vesicular transport, impairment of autophagy, change of intracellular signaling (aberrant activation of signaling pathways), abnormalities of calcium homeostasis, oxidative stress. Understanding of the cellular processes underlying the pathophysiology of MPS helps to address the limitations of the existing therapies and to identify new therapeutic targets, which potentially form additional and effective ways of the therapy of the patients with MPS.
Insights
Mucopolysaccharidoses (MPS) involve undegraded glycosaminoglycans triggering inflammation and organ damage. Understanding these cellular processes reveals new therapeutic targets for MPS patients.
Area of Science:
- Biochemistry
- Cell Biology
- Pathophysiology
Background:
- Mucopolysaccharidoses (MPS) are genetic disorders characterized by the accumulation of undegraded glycosaminoglycans (GAGs).
- This accumulation leads to cellular dysfunction and progressive damage across multiple organ systems.
- Current therapies for MPS have limitations in addressing the full spectrum of disease pathology.
Purpose of the Study:
- To review current knowledge on the role of GAGs in MPS pathophysiology.
- To elucidate the complex pathogenetic cascades initiated by undegraded GAGs.
- To identify novel therapeutic targets for MPS treatment.
Main Methods:
- Literature review of existing research on MPS and GAG metabolism.
- Analysis of cellular mechanisms involved in MPS pathogenesis.
- Synthesis of information on signaling pathways, cellular transport, and homeostasis.
Main Results:
- Undegraded GAGs act as potent stimulants for secondary pathogenetic events.
- These events include substrate accumulation, membrane abnormalities, impaired vesicular transport, disrupted autophagy, aberrant intracellular signaling, calcium dysregulation, and oxidative stress.
- The review details the complex interplay of these factors in MPS.
Conclusions:
- Understanding the cellular basis of MPS pathophysiology is crucial for improving treatment strategies.
- Identifying new therapeutic targets based on these cellular processes can lead to more effective therapies for MPS patients.
- This knowledge can help overcome limitations of current MPS treatments.
Related Concept Videos
Proteoglycans
Lysosomal Hydrolases
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Glycosaminoglycans
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
Oligosaccharide Assembly
Multiple sugar molecules that may or may...
Cohesins
Cohesin complexes in Meiotic Division
Meiosis involves two distinct rounds of chromosomal segregation and cell divisions— Meiosis I followed by Meiosis II – producing four daughter cells. Meiosis I includes the separation of...

